06.05.25 -- Outsourcing GLP-1 Programs: Is There Capacity For Biotechs?

Discover how developability assessments can streamline lead candidate selection in this Abzena webinar. Learn how evaluating key attributes like manufacturability, safety, and efficacy early in drug development helps reduce risks and improve clinical success rates. Explore advanced methodologies and technologies that provide comprehensive insights, enabling better decision-making and more efficient progress toward regulatory approval. Click here to learn more.

In developing a CDC assay for therapeutic mAb characterization or QC release testing, consideration should be made to the expression of CRPs on the cell surface.

By forging strategic partnerships with comprehensive CDMOs, see how emerging biopharma firms can navigate through early-phase development and ensure a smooth transition to clinical advancement.

Learn about the University of Queensland's rapid development of a vaccine candidate for COVID-19 and the role GS Xceed® system played in this project.

Orthogonal analytical techniques are essential to characterize CQAs, support regulatory submissions, and validate AI-predicted formulation strategies.

Navigate the challenging path from concept to clinical reality by partnering with an experienced CDMO that can provide the regulatory, clinical, and CMC expertise needed to move your therapeutic forward.

Scale-up challenges often arise when bioreactor geometry, design, mixing, or sparging differ from those used in initial process development, potentially compromising cell culture performance.

We're doubling down on growth, expanding its capabilities in combination product and drug-fill/finish manufacturing to meet the evolving needs of the biotech industry.

Strategically improve your upstream and downstream processes and decrease the timeline from optimization to commercial manufacturing.

Join Outsourced Pharma Live on June 11th at 2pm ET for a virtual panel discussion on the specific challenges of biologics development that must drive CDMOs to embrace more flexible approaches. Registration is free thanks to the support of Curia.

Backed by more than 30 years’ expe­rience and expertise, we offer our customers a full “one-stop-shop” service package at all stages of development and production.

Discover technology that enables a cost-effective, easily implemented cell line development workflow while delivering high productivity pools and cell lines.

Utilizing Singota's International SCM services involves cost savings, risk mitigation, logistics support, and streamlined communication.

The kojoX philosophy is designed to overcome capacity constraints, regulatory complexities, and geopolitical risks to deliver unmatched scale, speed, supply chain agility, and resilience.

Committed to customer-focused solutions, we’re proud to introduce our specialists to the global biopharma community and share insights that drive innovation forward.